サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1659459

プレシジョンメディシンの世界市場

Precision Medicine

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
プレシジョンメディシンの世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

プレシジョンメディシンの世界市場は2030年までに1,611億米ドルに達する見込み

2024年に974億米ドルと推定されるプレシジョンメディシンの世界市場は、2024年から2030年にかけてCAGR 8.7%で成長し、2030年には1,611億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断アプリケーションは、CAGR 8.5%を記録し、分析期間終了までに890億米ドルに達すると予測されます。治療薬アプリケーション分野の成長率は、分析期間中CAGR 9.0%と推定されます。

米国市場は250億米ドルと推定、中国はCAGR 12.8%で成長予測

米国のプレシジョンメディシン市場は2024年に250億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに413億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.3%と7.5%と予測されています。欧州では、ドイツがCAGR 5.3%で成長すると予測されています。

世界のプレシジョンメディシン市場- 主要動向と促進要因のまとめ

プレシジョンメディシンはどのようにヘルスケアを再構築しているのか？

プレシジョンメディシンは、遺伝的体質、環境、ライフスタイルに基づいて個々の患者に合わせた治療や介入を行うことで、ヘルスケアに革命をもたらしています。プレシジョンメディシンは、従来の"画一的な"医療アプローチとは異なり、健康や病気に影響を与える遺伝的、環境的、行動的要因を特定することで、ヘルスケアをカスタマイズすることを目指しています。このアプローチにより、より効果的な治療、病気の早期発見、予防戦略の向上が可能となり、最終的には患者の転帰改善につながります。

プレシジョンメディシンの重要な側面は、ゲノミクスに焦点を当てていることです。遺伝子検査は、患者が特定の薬や治療にどのように反応するかを決定するのに役立ちます。例えば、がん治療では、腫瘍のゲノム・プロファイリングにより、腫瘍医が特定の変異を同定し、その変異を標的としたオーダーメイドの治療が可能となり、副作用を最小限に抑えながら治療効果を向上させることができます。プレシジョンメディシンはまた、糖尿病、心血管疾患、自己免疫疾患などの慢性疾患の管理においても、患者固有の遺伝的危険因子を特定し、個別化された治療計画を策定することで重要な役割を果たしています。プレシジョンメディシンが進歩するにつれ、治療をより効率的にし、試行錯誤的な処方を減らし、より積極的なヘルスケアアプローチを可能にすることで、ヘルスケアシステムを変革する可能性を秘めています。

どのような技術革新がプレシジョンメディシンの成長を促進しているのでしょうか？

技術の進歩はプレシジョンメディシン革命の最前線にあり、ゲノミクス、ビッグデータ分析、人工知能（AI）、バイオテクノロジーにおける革新がその成長を牽引しています。最も重要なブレークスルーの1つは次世代シーケンサー（NGS）であり、これにより1人のゲノムの配列を決定するのに必要なコストと時間が大幅に削減されました。NGS技術によって包括的なゲノム・プロファイリングが可能になり、ヘルスケア提供者は病気に関連する特定の遺伝子変異を特定することができます。ゲノムデータは、がんや希少遺伝性疾患、その他遺伝的要素を持つ疾患の患者に対する個別化治療計画の開発にますます利用されるようになっています。

AIと機械学習もまた、プレシジョンメディシンにおいて重要な役割を果たしています。これらの技術は、研究者や臨床医が患者のゲノム、電子カルテ（EHR）、臨床試験結果などの膨大なデータセットを分析してパターンを特定し、治療結果を予測するのに役立っています。AIアルゴリズムは、複雑な遺伝子データや臨床データをふるいにかけ、特定の疾患に関連するバイオマーカーを特定し、早期診断やより的を絞った治療アプローチを可能にします。腫瘍学では、遺伝子プロファイルに基づいて患者を最も効果的ながん治療法に適合させるためにAIが使用されており、生存率を向上させ、侵襲的治療の必要性を減らしています。

ビッグデータ分析の台頭も、プレシジョンメディシンにおけるもう一つの重要な促進要因です。ウェアラブルデバイス、EHR、患者モニタリングシステムからの健康データの利用可能性が高まるにつれ、研究者は大規模な患者集団からのリアルタイムデータを分析できるようになった。このデータは、病気の進行、治療反応、健康に影響を与える環境やライフスタイルの要因に関する貴重な洞察を明らかにすることができます。この情報を遺伝子データと統合することで、開発者は個々の患者に対して、より総合的で個別化された治療計画を立てることができます。

さらに、CRISPR-Cas9のような遺伝子編集技術のようなバイオテクノロジーの進歩は、プレシジョンメディシンに新たな道を開いています。これらの技術は、患者の遺伝子コードに正確な修正を加えることを可能にし、遺伝病を根源から治療する可能性を提供します。特定の遺伝子変異や免疫反応を標的とする遺伝子治療や個別化ワクチンも、がんや感染症、その他の複雑な疾患との闘いにおける強力なツールとして台頭してきています。このような技術革新は、プレシジョンメディシンの採用を加速させ、より多くの患者にとってより利用しやすく効果的なものにしています。

規制当局のサポートと消費者の需要は、どのようにプレシジョンメディシンを推進しているのでしょうか？

プレシジョンメディシン市場は、規制当局のサポートと個別化ヘルスケアに対する消費者需要の増加から大きな影響を受けています。世界中の政府や規制機関は、プレシジョンメディシンがヘルスケアのアウトカムを改善し、コストを削減する可能性を認めています。米国では、2015年に開始されたプレシジョンメディシンイニシアチブ（PMI）が、個別化治療の拡大と医学研究の進展を目的として、研究開発への多額の投資を促進しています。同様に欧州では、欧州医薬品庁（EMA）などの規制機関が、特にがん、希少疾患、慢性疾患における精密治療の開発を推進しています。こうした取り組みにより官民の連携が促進され、プレシジョンメディシン技術の開発と承認が加速しています。

規制当局もまた、精密治療や診断ツールの承認プロセスの合理化に取り組んでいます。例えば、米国食品医薬品局（FDA）はコンパニオン診断薬の審査を迅速化するためのパスウェイを確立しました。コンパニオン診断薬は、しばしば標的治療薬とともに使用され、臨床医が患者の遺伝子プロファイルに基づいて治療を調整することを可能にするため、プレシジョンメディシンの重要な要素です。このような規制上の支援は、製薬会社がより個別化された治療法や診断薬の開発に投資することを促し、市場成長をさらに促進しています。

消費者側では、患者が自分の健康についてより多くの情報を得るようになり、個々のニーズに合わせた治療を求めるようになっているため、個別化ヘルスケアソリューションに対する需要が高まっています。23andMeやAncestryDNAのような直接消費者に提供される遺伝子検査サービスの台頭は、個人の遺伝とそれが健康に及ぼす影響を理解することへの一般の関心を喚起しました。患者は、より良い治療成績と副作用の少ない、オーダーメイドの治療計画を受けるために、遺伝子検査を受け、自分の健康データを共有することに積極的になっています。例えば腫瘍学では、生存期間とQOLを改善する可能性のある標的療法を特定するために、患者や介護者がゲノム検査を擁護する傾向が強まっています。

さらに、がん、糖尿病、心血管疾患などの慢性疾患の増加により、より正確で効果的な治療に対する需要が高まっています。プレシジョンメディシンは、遺伝的、環境的、ライフスタイル的要因を考慮することで、これらの疾患の複雑性に対処できるソリューションを提供します。ヘルスケアシステムが、より良い治療結果をより低いコストで提供することに重点を置くバリューベースのケアモデルへとシフトする中、プレシジョンメディシンは、治療効果を高め、不必要な処置を減らし、医療費を最小限に抑える方法として注目されています。規制の影響、技術革新、消費者の需要の高まりが相まって、プレシジョンメディシン市場は前進しており、ヘルスケアの将来に幅広い影響を及ぼしています。

プレシジョンメディシン市場の主な成長促進要因は？

プレシジョンメディシン市場は、技術の進歩、ヘルスケア支出の増加、個別化治療の重視の高まりが相まって、急速な成長を遂げています。主な成長要因の1つは、ゲノムシーケンシングのコスト低下であり、これにより遺伝子検査がより多くの人々にとって身近なものとなっています。全ゲノムシークエンシングの価格が下がり続けているため、より多くの患者やヘルスケアプロバイダーが、特に遺伝子変異が治療選択の指針となることが多い腫瘍学において、治療方針の決定に遺伝データを活用するようになっています。このシフトは、精密治療やコンパニオン診断の市場を拡大し、製薬企業やバイオテクノロジー企業に新たな機会をもたらしています。

慢性疾患の増加もプレシジョンメディシン市場の重要な促進要因です。がん、糖尿病、心血管疾患、その他の慢性疾患の罹患率が世界的に上昇を続ける中、より効果的で的を絞った治療に対するニーズが高まっています。プレシジョンメディシンは、これらの疾患を持つ患者に対して、より個別化された治療を提供し、転帰を改善し、従来の治療にしばしば伴う試行錯誤のアプローチを軽減する可能性を提供します。例えば腫瘍学では、プレシジョンメディシンは特定のがんの原因となる突然変異を攻撃する標的治療の開発につながり、従来の化学療法と比較してより効果的で毒性の低い治療を実現しています。

製薬会社もまた、標的療法やプレシジョンベースの薬剤の開発に多額の投資を行うことで、市場の成長を牽引しています。バイオマーカーやコンパニオン診断薬の開発が進むにつれ、医薬品開発企業は特定の遺伝子や分子プロファイルに合わせた治療法を設計できるようになっています。このような標的を絞ったアプローチは、臨床転帰を成功に導く可能性を高め、副作用のリスクを低減し、より効率的な医薬品開発プロセスにつながります。さらに、特定の患者集団を治療するために設計された免疫療法や遺伝子治療の台頭は、様々な治療領域におけるプレシジョンメディシンアプリケーションの拡大に寄与しています。

最後に、人工知能（AI）と機械学習のヘルスケアへの統合が、プレシジョンメディシンの採用を加速しています。AIを駆使したツールは、臨床医や研究者が遺伝子情報、臨床記録、ライフスタイルデータなどの大規模なデータセットを分析し、個々の患者にとって最も効果的な治療を特定するのに役立っています。これらのテクノロジーは診断のスピードと精度を向上させ、早期介入と個別化された治療計画を可能にしています。ウェアラブルデバイスやモバイルヘルスアプリケーションから得られる健康データの利用可能性が高まることで、患者の行動に関する貴重な洞察も得られ、より包括的かつ継続的な健康成果のモニタリングが可能になりつつあります。

ヘルスケア業界が個別化ケアとテクノロジー主導のソリューションを優先し続ける中、プレシジョンメディシン市場は今後数年間で大きく成長すると予想されます。これらの成長要因は、ゲノム、AI、バイオテクノロジーにおける継続的な進歩と相まって、より的を絞った、効果的な、患者中心のヘルスケアソリューションへの道を開いています。

セグメント

最終用途（診断薬、治療薬）;最終用途（臨床検査室、病院、在宅ケア、その他の最終用途）

調査対象企業の例（注目の42社）

  • 23andMe, Inc.
  • Abbott Laboratories
  • Biogen
  • Dako A/S
  • F. Hoffmann-La Roche Ltd.-Foundation Medicine
  • Foundation Medicine Inc.
  • GE Healthcare
  • IBM Watson
  • Illumina
  • Janssen Pharmaceuticals
  • Medtronic
  • Myriad Genetics Inc.
  • NeoDiagnostix, Inc.
  • Precision Biologics Incorporated
  • Qiagen Incorporated
  • Quest Diagnostics Incorporated
  • Siemens Healthineers

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22613

Global Precision Medicine Market to Reach US$161.1 Billion by 2030

The global market for Precision Medicine estimated at US$97.4 Billion in the year 2024, is expected to reach US$161.1 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Diagnostics Application, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$89.0 Billion by the end of the analysis period. Growth in the Therapeutics Application segment is estimated at 9.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.0 Billion While China is Forecast to Grow at 12.8% CAGR

The Precision Medicine market in the U.S. is estimated at US$25.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$41.3 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Precision Medicine Market - Key Trends & Drivers Summarized

How Is Precision Medicine Reshaping Healthcare?

Precision medicine is revolutionizing healthcare by tailoring medical treatments and interventions to individual patients based on their genetic makeup, environment, and lifestyle. Unlike traditional "one-size-fits-all" approaches to medicine, precision medicine aims to customize healthcare by identifying the genetic, environmental, and behavioral factors that influence health and disease. This approach allows for more effective treatments, earlier disease detection, and improved prevention strategies, ultimately leading to better patient outcomes.

A key aspect of precision medicine is its focus on genomics, where genetic testing helps determine how patients will respond to certain medications or treatments. For example, in cancer treatment, genomic profiling of tumors allows oncologists to identify specific mutations that can be targeted with tailored therapies, improving the effectiveness of treatments while minimizing side effects. Precision medicine also plays a critical role in managing chronic diseases such as diabetes, cardiovascular conditions, and autoimmune disorders by identifying patients' unique genetic risk factors and developing personalized treatment plans. As precision medicine advances, it holds the potential to transform healthcare systems by making treatments more efficient, reducing trial-and-error prescribing, and enabling more proactive healthcare approaches.

What Technological Innovations Are Driving The Growth Of Precision Medicine?

Technological advancements are at the forefront of the precision medicine revolution, with innovations in genomics, big data analytics, artificial intelligence (AI), and biotechnology driving its growth. One of the most significant breakthroughs is in next-generation sequencing (NGS), which has drastically reduced the cost and time required to sequence a person’s genome. NGS technology allows for comprehensive genomic profiling, enabling healthcare providers to identify specific genetic mutations associated with diseases, which can then be targeted with precision therapies. Genomic data is being increasingly used to develop personalized treatment plans for patients with cancer, rare genetic disorders, and other conditions that have a genetic component.

AI and machine learning are also playing a crucial role in the precision medicine landscape. These technologies are helping researchers and clinicians analyze vast datasets, such as patient genomes, electronic health records (EHRs), and clinical trial results, to identify patterns and predict treatment outcomes. AI algorithms can sift through complex genetic and clinical data to pinpoint biomarkers associated with specific diseases, enabling earlier diagnosis and more targeted treatment approaches. In oncology, AI is being used to match patients with the most effective cancer therapies based on their genetic profiles, improving survival rates and reducing the need for invasive treatments.

The rise of big data analytics is another key driver in precision medicine. With the growing availability of health data from wearable devices, EHRs, and patient monitoring systems, researchers can now analyze real-time data from large patient populations. This data can reveal valuable insights into disease progression, treatment responses, and the environmental or lifestyle factors that influence health. By integrating this information with genetic data, precision medicine practitioners can develop more holistic and personalized treatment plans for individual patients.

Furthermore, advancements in biotechnology, such as gene editing technologies like CRISPR-Cas9, are opening new avenues for precision medicine. These technologies allow for precise modifications to a patient’s genetic code, offering the potential to treat genetic diseases at their source. Gene therapies and personalized vaccines, which target specific genetic mutations or immune responses, are also emerging as powerful tools in the fight against cancer, infectious diseases, and other complex conditions. These technological innovations are accelerating the adoption of precision medicine, making it more accessible and effective for a wider range of patients.

How Are Regulatory Support And Consumer Demand Driving Precision Medicine?

The precision medicine market is being significantly influenced by regulatory support and increasing consumer demand for personalized healthcare. Governments and regulatory bodies worldwide are recognizing the potential of precision medicine to improve healthcare outcomes and reduce costs. In the United States, the Precision Medicine Initiative (PMI), launched in 2015, has driven substantial investment in research and development, with the aim of expanding personalized treatments and advancing medical research. Similarly, in Europe, regulatory agencies such as the European Medicines Agency (EMA) are promoting the development of precision therapies, particularly in oncology, rare diseases, and chronic conditions. These initiatives are fostering collaboration between public and private sectors, accelerating the development and approval of precision medicine technologies.

Regulatory agencies are also working to streamline the approval process for precision therapies and diagnostic tools. For instance, the U.S. Food and Drug Administration (FDA) has established pathways to expedite the review of companion diagnostics, which are essential for identifying patients who are likely to benefit from specific treatments. Companion diagnostics, often used alongside targeted therapies, are critical components of precision medicine, as they enable clinicians to tailor treatments based on patients’ genetic profiles. This regulatory support is encouraging pharmaceutical companies to invest in the development of more personalized therapies and diagnostics, further driving market growth.

On the consumer side, there is a growing demand for personalized healthcare solutions, as patients become more informed about their health and increasingly seek treatments that are tailored to their individual needs. The rise of direct-to-consumer genetic testing services, such as 23andMe and AncestryDNA, has sparked public interest in understanding personal genetics and its impact on health. Patients are more willing to undergo genetic testing and share their health data to receive tailored treatment plans that offer better outcomes and fewer side effects. In oncology, for instance, patients and caregivers are increasingly advocating for genomic testing to identify targeted therapies that may improve survival and quality of life.

Additionally, the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is driving the demand for more precise and effective treatments. Precision medicine offers solutions that can address the complexities of these conditions by considering genetic, environmental, and lifestyle factors. As healthcare systems shift toward value-based care models, where the focus is on delivering better outcomes at lower costs, precision medicine is being seen as a way to enhance treatment efficacy, reduce unnecessary procedures, and minimize healthcare spending. The combination of regulatory support, technological innovation, and rising consumer demand is propelling the precision medicine market forward, with wide-ranging implications for the future of healthcare.

What Are The Key Growth Drivers In The Precision Medicine Market?

The precision medicine market is experiencing rapid growth, driven by a combination of technological advancements, increased healthcare spending, and a growing emphasis on personalized treatments. One of the primary growth drivers is the declining cost of genomic sequencing, which is making genetic testing more accessible to a larger population. As the price of whole genome sequencing continues to fall, more patients and healthcare providers are utilizing genetic data to inform treatment decisions, particularly in oncology, where genetic mutations often guide therapy choices. This shift is expanding the market for precision therapies and companion diagnostics, creating new opportunities for pharmaceutical and biotechnology companies.

The increasing prevalence of chronic diseases is another significant driver of the precision medicine market. As rates of cancer, diabetes, cardiovascular disease, and other chronic conditions continue to rise globally, there is a growing need for more effective and targeted treatments. Precision medicine offers the potential to deliver more personalized care for patients with these conditions, improving outcomes and reducing the trial-and-error approach often associated with conventional treatments. In oncology, for example, precision medicine has led to the development of targeted therapies that attack specific cancer-causing mutations, resulting in more effective and less toxic treatments compared to traditional chemotherapy.

Pharmaceutical companies are also driving market growth by investing heavily in the development of targeted therapies and precision-based drugs. The growing use of biomarkers and companion diagnostics is allowing drug developers to design treatments that are tailored to specific genetic or molecular profiles. This targeted approach increases the likelihood of successful clinical outcomes and reduces the risks of adverse reactions, leading to more efficient drug development processes. Additionally, the rise of immunotherapy and gene therapies, which are designed to treat specific patient populations, is contributing to the expansion of precision medicine applications across various therapeutic areas.

Lastly, the integration of artificial intelligence (AI) and machine learning into healthcare is accelerating the adoption of precision medicine. AI-driven tools are helping clinicians and researchers analyze large datasets, including genetic information, clinical records, and lifestyle data, to identify the most effective treatments for individual patients. These technologies are improving the speed and accuracy of diagnosis, enabling earlier intervention and personalized treatment plans. The increasing availability of health data from wearable devices and mobile health applications is also providing valuable insights into patient behavior, allowing for more comprehensive and continuous monitoring of health outcomes.

As the healthcare industry continues to prioritize personalized care and technology-driven solutions, the precision medicine market is expected to grow significantly in the coming years. These growth drivers, combined with ongoing advancements in genomics, AI, and biotechnology, are paving the way for more targeted, effective, and patient-centered healthcare solutions.

SCOPE OF STUDY:

The report analyzes the Precision Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Diagnostics, Therapeutics); End-Use (Clinical Laboratories, Hospitals, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 23andMe, Inc.
  • Abbott Laboratories
  • Biogen
  • Dako A/S
  • F. Hoffmann-La Roche Ltd.-Foundation Medicine
  • Foundation Medicine Inc.
  • GE Healthcare
  • IBM Watson
  • Illumina
  • Janssen Pharmaceuticals
  • Medtronic
  • Myriad Genetics Inc.
  • NeoDiagnostix, Inc.
  • Precision Biologics Incorporated
  • Qiagen Incorporated
  • Quest Diagnostics Incorporated
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Precision Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Personalized Healthcare Drives Demand for Precision Medicine Solutions Tailored to Individual Patients
    • Advancements in Genomic Sequencing Technologies Propel Growth in Precision Medicine for Early Disease Detection and Prevention
    • Rising Adoption of AI and Machine Learning Strengthens Data-Driven Insights in Precision Medicine for Targeted Therapies
    • Growing Emphasis on Cancer Treatment Expands Market for Precision Medicine in Oncology
    • Increasing Use of Biomarker-Based Diagnostics Generates Demand for Precision Medicine in Personalized Treatment Plans
    • Growth of Direct-to-Consumer Genetic Testing Expands Opportunities for Precision Medicine in Preventive Healthcare
    • Rising Focus on Rare Diseases Drives Development of Precision Medicine Solutions for Niche Patient Populations
    • Technological Advancements in Bioinformatics Spur Innovation in Precision Medicine for Integrating Complex Patient Data
    • Expansion of Pharmacogenomics Strengthens the Business Case for Precision Medicine to Optimize Drug Efficacy and Safety
    • Growing Focus on Reducing Healthcare Costs Propels Adoption of Precision Medicine to Improve Treatment Outcomes and Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Precision Medicine Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Precision Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Precision Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Precision Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Precision Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Precision Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Precision Medicine by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Precision Medicine by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Precision Medicine by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Precision Medicine by End-Use - Clinical Laboratories, Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Precision Medicine by End-Use - Percentage Breakdown of Value Sales for Clinical Laboratories, Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION